Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| INCYTE | 7 | 18 | +0,41 % | ||
| AMGEN | 6 | 12 | +0,76 % | ||
| BLUEBIRD BIO | 6 | 10 | +0,32 % | ||
| SEATTLE GENETICS | 5 | 13 | -0,89 % | ||
| ENDO | 4 | 4 | +6,25 % | ||
| RESTORBIO | 4 | 4 | +2,21 % | ||
| GILEAD SCIENCES | 3 | 16 | 0,00 % | ||
| AMARIN | 3 | 7 | -1,18 % | ||
| REATA PHARMACEUTICALS | 3 | 3 | -2,83 % | ||
| EPIZYME | 2 | 8 | +1,71 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08:07 | XFRA 19D: AUSSETZUNG/SUSPENSION | - | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT: THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL DERMIRA INC.... ► Artikel lesen | |
| 05:40 | FDA Delays Decision On HRTX Drug, KPTI On Watch, ADMP To Resubmit NDA In Q2 | 160 | AFX News | SOUTH SAN FRANCISCO (dpa-AFX) - Today's Daily Dose brings you news about Adamis Pharma's upcoming regulatory catalyst, the delay in FDA decision related to Eton Pharma's drug candidate, the... ► Artikel lesen | |
| 02:58 | Reata Pharmaceuticals, Inc. (RETA) CEO Warren Huff on Q4 2019 Results - Earnings Call Transcript | 3 | Seeking Alpha | ||
| 02:46 | Fantastic Buying Opportunity For BDSI | 3 | Seeking Alpha | ||
| 02:12 | RCKT Mortgage Trust 2020-1 -- Moody's assigns definitive ratings to Prime RMBS issued by RCKT Mortgage Trust 2020-1 | 1 | Moody's Ratings | ||
| 02:10 | Amarin: Stalking Another Buy Around Fourth-Quarter Report | 7 | Seeking Alpha | ||
| 01:05 | BRIEF-Bridgebio Pharma Increased Size Of Co's Board From Seven To Eight Directors | 1 | Reuters.com | ||
| 00:34 | Genmab A/S (GNMSF) CEO Jan van de Winkel on Q4 2019 Results - Earnings Call Transcript | 1 | Seeking Alpha | ||
| 00:12 | Sanofi to repurpose SARS vaccine candidate for coronavirus | 2 | PharmaTimes | ||
| Mi | PRA Health Sciences Q4 2019 Earnings Preview | - | Seeking Alpha | ||
| Mi | XBiotech Inc.: XBiotech gibt endgültige Ergebnisse seines Rückkaufangebots bekannt | 854 | GlobeNewswire (Deutschland) | AUSTIN, Texas, Feb. 19, 2020 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) ("XBiotech") hat heute die endgültigen Ergebnisse seines Rückkaufangebots im Stile einer "abgewandelten holländischen... ► Artikel lesen | |
| Mi | BridgeBio Pharma, Inc. - 8-K, Current Report | - | SEC Filings | ||
| Mi | BRIEF-Endo Names Blaise Coleman President And Chief Executive Officer | - | Reuters.com | ||
| Mi | Five Prime grabs $5M lifeline in Seattle Genetics ADC deal | 1 | FierceBiotech | ||
| Mi | AGIOS PHARMACEUTICALS, INC. - S-8, Securities to be offered to employees in employee benefit plans | - | SEC Filings | ||
| Mi | Endo International plc - 8-K, Current Report | 3 | SEC Filings | ||
| Mi | Endo Names Blaise Coleman President and Chief Executive Officer | 153 | PR Newswire | Mark Bradley Named Executive Vice President and Chief Financial Officer
DUBLIN, Feb. 19, 2020 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that Blaise Coleman... ► Artikel lesen | |
| Mi | Endo Appoints Mark G. Barberio to Board of Directors | 139 | PR Newswire | DUBLIN, Feb. 19, 2020 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that its Board of Directors has appointed Mark G. Barberio to serve as a director, effective... ► Artikel lesen | |
| Mi | AGIOS PHARMACEUTICALS, INC. - 10-K, Annual Report | - | SEC Filings | ||
| Mi | REATA PHARMACEUTICALS INC - 10-K, Annual Report | 1 | SEC Filings |
Seite:
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
